Prostate drug linked to serious side effects

A common drug called Avodart (Dutsteride) that is prescribed for benign prostatic hyperplasia (BPH) has been associated with an increased risk for diabetes, elevated cholesterol levels,  liver disease and worsening erectile dysfunction, reports Boston University Medical Center researchers. BPH is a common condition in men as they age, resulting in an enlarged prostate. Men seeking relief from the symptoms (including frequent nighttime urination) may be treated with drugs, such as Avodart, or surgery. The recent announcement on Avodart’s side effects from the study published in Hormones Molecular Biology and Clinical Investigations highlights the need for alternative treatment methods for BPH.

Parsemus Foundation supported a study in dogs with naturally occurring BPH which found significant improvements with a simple, noninvasive treatment using pulsed electromagnetic field therapy. The therapy increased blood flow and decreased prostate volume by 57% in the dogs. We are currently seeking physicians interested in using this method to confirm the same positive outcomes in men. It could prove to be a simple, inexpensive, painless and noninvasive treatment for one of the most common ailments of older men!

Linda Brent, PhD

Executive Director, Parsemus Foundation

Tell us what you think

This form does not collect your email address. If you would like us to respond, please send questions to
This field is for validation purposes and should be left unchanged.
We’re sorry, you are not eligible for the nationwide COVID-OUT or ACTIV-6 studies, but you may be eligible for other federal trials:

And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well:

Trials Today